Collection and processing of mucosal secretions from mice

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• The primary transmission route for human immunodeficiency virus type 1 (HIV-1) is through mucosal surfaces, particularly in the genital tract.
• Immune responses at mucosal sites are hypothesized to be crucial for protection against HIV-1 infection.
• Developing preventive HIV-1 vaccines may necessitate the induction of local mucosal immunity.

Purpose of the Study:

• To review the induction of mucosal immune responses following different mucosal immunization routes.
• To assess the potential of mucosal immunization for developing effective HIV-1 vaccines.

Main Methods:

• Examination of specific mucosal immune responses elicited by various mucosal immunization routes in rodents.
• Review of studies investigating nasal and oral immunization with HIV-1 peptides and whole proteins in mice.
• Analysis of research on inducing mucosal and systemic immunity to SIV and HIV-1 antigens in primates via mucosal routes.

Main Results:

• Nasal and oral immunization routes have demonstrated the ability to elicit robust mucosal immune responses to HIV-1 antigens in mice.
• Various mucosal vaccine administration routes have successfully induced both mucosal and systemic immunity to SIV and HIV-1 antigens in primates.

Conclusions:

• Mucosal immunization strategies, particularly via nasal and oral routes, show promise for inducing protective immunity against HIV-1.
• Further development of mucosal vaccines is critical for achieving effective prevention of HIV-1 transmission.